Suntrust Banks Inc. cut its stake in Monsanto (NYSE:MON) by 61.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,379 shares of the basic materials company’s stock after selling 39,789 shares during the period. Suntrust Banks Inc.’s holdings in Monsanto were worth $2,962,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently modified their holdings of MON. Harding Loevner LP raised its holdings in shares of Monsanto by 140.0% in the 3rd quarter. Harding Loevner LP now owns 2,294,152 shares of the basic materials company’s stock worth $111,903,000 after buying an additional 1,338,271 shares in the last quarter. Capital International Investors raised its holdings in shares of Monsanto by 10.3% in the 3rd quarter. Capital International Investors now owns 9,344,430 shares of the basic materials company’s stock worth $1,119,650,000 after buying an additional 872,377 shares in the last quarter. Janus Henderson Group PLC raised its holdings in shares of Monsanto by 57.1% in the 3rd quarter. Janus Henderson Group PLC now owns 2,342,693 shares of the basic materials company’s stock worth $280,696,000 after buying an additional 851,369 shares in the last quarter. Boussard & Gavaudan Investment Management LLP raised its holdings in shares of Monsanto by 272.2% in the 4th quarter. Boussard & Gavaudan Investment Management LLP now owns 768,080 shares of the basic materials company’s stock worth $89,627,000 after buying an additional 561,716 shares in the last quarter. Finally, Bank of Montreal Can raised its holdings in shares of Monsanto by 75.1% in the 4th quarter. Bank of Montreal Can now owns 1,043,409 shares of the basic materials company’s stock worth $121,850,000 after buying an additional 447,662 shares in the last quarter. 73.70% of the stock is owned by institutional investors and hedge funds.
MON has been the topic of a number of research analyst reports. Royal Bank of Canada restated a “hold” rating and set a $128.00 price target on shares of Monsanto in a research report on Wednesday, November 15th. Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a research report on Monday, December 11th. Deutsche Bank restated a “buy” rating on shares of Monsanto in a research report on Tuesday, January 16th. Finally, Wells Fargo & Co restated a “market perform” rating and set a $128.00 price target (up from $118.00) on shares of Monsanto in a research report on Wednesday, January 17th. Eleven analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $127.30.
Monsanto (NYSE:MON) last released its quarterly earnings results on Thursday, January 4th. The basic materials company reported $0.41 EPS for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.01). The business had revenue of $2.66 billion for the quarter, compared to the consensus estimate of $2.77 billion. Monsanto had a return on equity of 40.13% and a net margin of 16.38%. The firm’s revenue was up .3% on a year-over-year basis. During the same quarter last year, the company earned $0.21 earnings per share. analysts anticipate that Monsanto will post 5.76 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, April 6th will be given a $0.54 dividend. The ex-dividend date of this dividend is Thursday, April 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.75%. Monsanto’s payout ratio is 39.85%.
In other Monsanto news, EVP Steven Mizell sold 8,100 shares of the stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total value of $966,735.00. Following the transaction, the executive vice president now directly owns 56,743 shares in the company, valued at approximately $6,772,277.05. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.70% of the stock is currently owned by company insiders.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.